Cancer Research UK logo.
SearchDonate
  • Search

A study looking at AZD8205 for cancer that has spread or come back after treatment (Sub-study 1)

Overview

Cancer types:

Bile duct cancer, Biliary tree cancers, Breast cancer, Ovarian cancer, Secondary cancers, Womb (uterine or endometrial) cancer

Status:

Open

Phase:

Phase 1/2

Details

This study is looking at a drug called AZD8205. It is for solid cancers that have spread to another part of the body or have come back after treatment. A solid cancer is any cancer apart from a blood cancer such as leukaemia.

It is open to people with:

  • breast cancer

  • bile duct cancer

  • ovarian cancer

  • womb (endometrial) cancer

Recruitment start: 31 October 2023

Recruitment end: 29 October 2025

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Peter Schmid

Supported by

AstraZeneca

Last reviewed: 28 January 2024

CRUK internal database number: 19421

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.